What are the indications, procedural steps, efficacy outcomes, and safety profile of EZ‑Gel platelet‑rich fibrin (PRF) as a regenerative filler in healthy adults aged 18–65 without active infection, bleeding disorders, uncontrolled diabetes, or immunosuppression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

EZ-Gel PRF: Clinical Applications and Evidence

Direct Answer

EZ-Gel PRF is an autologous platelet-rich fibrin preparation that has demonstrated efficacy as a regenerative biomaterial in facial aesthetics, periocular rejuvenation, and tissue regeneration, with the most robust evidence supporting its use when prepared using a heating protocol of 75°C for 10 minutes to create an injectable gel with prolonged degradation resistance and superior mechanical properties 1.

Preparation Protocol

The optimal EZ-Gel (albumin-PRF or heated PRF gel) preparation follows this algorithmic approach:

Blood Collection and Initial Centrifugation

  • Draw 9-10 mL tubes of whole blood without anticoagulants
  • Centrifuge at 700-2000 RCF (or 2000g) for 8 minutes in a horizontal centrifuge 2
  • This separates blood into distinct layers: platelet-poor plasma (PPP) on top, liquid PRF with buffy coat in middle, and red blood cells at bottom

Heat Treatment Protocol

  • Collect 2-4 mL of the upper PPP layer using a syringe 2
  • Place PPP-filled syringes in heating apparatus at 75°C for exactly 10 minutes 1
  • This temperature produces the fastest solidification time (over 10-fold increase), best resistance to degradation, and maintains >90% cell viability 1
  • Cool to room temperature for approximately 10 minutes 2

Final Gel Preparation

  • Collect the liquid PRF layer including buffy coat separately
  • Mix heated albumin gel with native liquid PRF using female-female luer lock connector 2
  • Results in injectable gel with 4-6 months resorption properties 2

Clinical Indications and Efficacy

Facial Volume Restoration and Aesthetics

Superior sulcus (upper eyelid) hollowing: Injectable PRF demonstrated significant depth reduction from 13.3±2.8 mm to 9.2±3.7 mm at 3 months (p=0.002), with 75% patient satisfaction and zero adverse events 3. Protocol: three sessions spaced 1 week apart, injected suborbicularis.

Tear trough and facial wrinkles: PPP gel (Bio-Filler) showed immediate significant improvement maintained through 3-month follow-up, with objective measurement via Wrinkle Severity Rating Scale and Tear Trough Rating Scale 2.

Periorbital rejuvenation: PRF improved skin texture and wrinkles more effectively than standard PRP, while PRP showed better results for pigmentation 4.

Surgical Applications

Rhinoplasty: PRF decreased cartilage resorption and improved graft stability, while also improving wound healing and reducing crusting 4.

Fat grafting: PRF demonstrated superior remodeling and long-term graft retention compared to fat alone 4.

Rhytidectomy: Modest reductions in postoperative edema and ecchymosis 4.

Hair Restoration

PRF showed 62-97% improvements in hair density within 3-6 months, with fastest and most consistent responses among regenerative modalities for androgenetic alopecia 5. Additional benefits when combined with hair transplantation procedures.

Biological Mechanisms

The heated PRF gel functions through multiple pathways:

  • Structural advantage: Heating at 75°C creates denser fibrin architecture with improved mechanical properties and rheologic behavior 1
  • Prolonged release: Natural fibrin matrix provides sustained growth factor delivery over months rather than weeks 6
  • Immunomodulation: Concentrated leukocytes regulate inflammation, angiogenesis, and cellular migration 7
  • Osteogenic potential: Cytokine networks and osteoimmunological interactions coordinate tissue regeneration 7

Safety Profile

All studies reported only mild, transient adverse events with no serious complications 3, 4, 5. The autologous nature eliminates risks of:

  • Allergic reactions
  • Disease transmission
  • Foreign body reactions
  • Vascular occlusion (theoretical advantage over synthetic fillers, though requires further study) 2

Critical Caveats and Pitfalls

Temperature Precision Matters

Lower temperatures (45°C, 60°C) produce inferior mechanical properties and faster degradation. Higher temperatures (90°C) may compromise bioactivity. The 75°C/10-minute protocol is non-negotiable for optimal outcomes 1.

Timing Constraints

  • Prepare all equipment before blood draw 2
  • PRF membranes remain viable only 3 hours if kept covered and moist 8
  • Immediate processing after centrifugation is critical

Centrifugation Variables

  • G-force must be calculated based on centrifuge radius 8
  • Centrifuge must be on stable surface to prevent vibration 8
  • For patients on anticoagulants, extend centrifugation to 18-20 minutes 8

Technique-Dependent Outcomes

When collecting PRF clots, do not cut away the face portion—this contains the highest concentration of platelets and leukocytes (the most biologically active part) 8. Gentle separation from red blood cells is essential.

Comparison to Standard PRF

Standard L-PRF (centrifuged at 408g for 12 minutes without heating) has ~2-week resorption rate 1, 6. The heated gel modification extends this to 4-6 months 2, making it more suitable for volume restoration applications where synthetic fillers would traditionally be used.

Evidence Quality Assessment

The heating protocol evidence 1 represents controlled laboratory investigation with objective mechanical and biological endpoints. Clinical facial aesthetic outcomes 2, 3 come from case series and retrospective studies—lower evidence quality but consistent positive signals. The systematic review of regenerative modalities 5 provides comparative context showing PRF's competitive efficacy profile. Current evidence supports clinical use but requires larger randomized controlled trials with standardized protocols and extended follow-up 4, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.